From L-R: CEPI CEO Richard Hatchett, CEO of CEPI, Second Vice Minister of the Ministry of Health and Welfare (MOHW) Park Min-soo, and vice chairman of SK discovery Chang Won (Andrew) Chey, at the signing ceremony on Oct. 25, 2022 (PR Newswire)
October 25, 2022 11:00 AM EDT
Deals

CEPI teams up with Ko­re­an vac­cine mak­er in $140M pact to scale up its nascent mR­NA plat­form

Amber Tong

Just a month af­ter ship­ping out the ini­tial batch of its home­grown nanopar­ti­cle Covid-19 vac­cines, South Ko­rea’s SK bio­science has signed a deal with the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Sarep­ta li­cens­es Ar­row­head­'s RNA-based rare dis­ease pipeline, promis­ing big biobucks

Up­dat­ed: Am­gen obe­si­ty shot shows 20% weight loss, but dos­ing ques­tions hang over read­out

Up­dat­ed: Roche buys out CAR-T part­ner Po­sei­da for $1B up­front

Food al­ler­gy biotech Al­ladapt clos­es af­ter Phase 3 talks with FDA

Alec­tor says Alzheimer's pro­gram tar­get­ing mi­croglia fails Phase 2, stock dives

Roche’s TIG­IT drug miss­es last shot at sur­vival end­point win in Phase 3 lung can­cer tri­al

A service from the Financial Times